4//SEC Filing
Wilfong Diane E. 4
Accession 0001415889-24-010568
CIK 0001445499other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 4:20 PM ET
Size
12.6 KB
Accession
0001415889-24-010568
Insider Transaction Report
Form 4
Wilfong Diane E
Director
Transactions
- Other
Stock Option (right to buy)
2024-04-05−31,356→ 0 totalExercise: $8.02Exp: 2029-11-20→ Common Stock (31,356 underlying) - Other
Stock Option (right to buy)
2024-04-05−11,500→ 0 totalExercise: $9.96Exp: 2031-07-10→ Common Stock (11,500 underlying) - Other
Stock Option (right to buy)
2024-04-05−12,789→ 0 totalExercise: $8.65Exp: 2032-06-15→ Common Stock (12,789 underlying) - Other
Stock Option (right to buy)
2024-04-05−13,222→ 0 totalExercise: $1.34Exp: 2033-06-15→ Common Stock (13,222 underlying)
Footnotes (3)
- [F1]Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery.
- [F2]The option was fully vested.
- [F3]The option was scheduled to vest in full as of June 16, 2024.
Documents
Issuer
IPI Legacy Liquidation Co
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001374988
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 4:20 PM ET
- Size
- 12.6 KB